Skip to main content

Day: July 22, 2025

Applied Materials Appoints Jim Anderson to Board of Directors

Jim AndersonJim Anderson joins Applied Materials’ Board of DirectorsSANTA CLARA, Calif., July 22, 2025 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced the appointment of Jim Anderson to serve on its board of directors. Mr. Anderson brings over 25 years of experience in the technology sector and semiconductor ecosystem. Mr. Anderson has also been appointed to the board’s Strategy and Investment Committee. “We are excited to welcome Jim to our board,” said Tom Iannotti, Chairman of the Board. “Jim’s extensive experience in innovation-driven technology businesses will be invaluable as we scale Applied Materials and address the tremendous opportunities ahead.” Mr. Anderson has served as the Chief Executive Officer and a member of the Board of Directors of Coherent Corp., a global leader in photonics for the...

Continue reading

Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.

GARDEN CITY, N.Y., July 22, 2025 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, has been awarded a national group purchasing agreement for therapeutic gases with Premier, Inc. Effective July 15th, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the LungFit PH system and disposable NO2 Smart Filters. “We are proud to have been awarded this agreement with Premier, expanding access to our LungFit PH system across their extensive network of U.S. hospitals and healthcare providers. The agreement helps streamline the sales process for the Premier hospital network...

Continue reading

First Bank Welcomes Chris Layne as Greater Richmond Market Executive

STRASBURG, Va., July 22, 2025 (GLOBE NEWSWIRE) — First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC), the bank holding company of First Bank (the “Bank”) is pleased to announce the addition of Chris Layne as Senior Vice President, Regional Market Executive for Richmond. Chris will be responsible for all lines of business banking and business development in the Richmond market.“We’re proud to welcome Chris to the First Bank team as our new market leader for the greater Richmond region. His deep roots in the community and proven leadership will strengthen our commitment to local relationships and personalized service,” said Scott C. Harvard, CEO of First National Corporation and First Bank. “At First Bank, we believe in the Power of One – one community, one team, one trusted partner – and Chris embodies...

Continue reading

SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification

Tel Aviv, July 22, 2025 (GLOBE NEWSWIRE) — SciSparc Ltd. (“SciSparc” or the “Company”) (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, reported the receipt on July 18, 2025 of a written notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has regained compliance with Listing Rule 5550(a)(2), which requires the Company’s ordinary shares to maintain a minimum bid price of $1.00 per share. The Nasdaq staff made this determination of compliance after the closing bid price of the Company’s ordinary shares was at $1.00 per share or greater for 10 consecutive business days. Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and Nasdaq considers the prior...

Continue reading

trivago N.V.’s Second Quarter 2025 Earnings Release Scheduled for August 5, 2025; Webcast Scheduled for August 6, 2025

  DÜSSELDORF, GERMANY – July 22, 2025 – trivago N.V. (NASDAQ: TRVG) announced today that it will release its financial results for the second quarter for the period ended June 30, 2025 on Tuesday, August 5, 2025 after market close. On Wednesday, August 6, 2025, trivago N.V.’s management will conduct a webcast beginning at 2:15 PM CEST / 8:15 AM EDT. These items will be available in the Investor Relations section of the company’s website at https://ir.trivago.com/. A replay of the call is expected to be available for at least three months.   About trivago N.V. trivago N.V. (NASDAQ: TRVG) is a leading global hotel search and price comparison platform and one of the most recognized travel brands in the world. When price savvy travelers are searching for a hotel, we want trivago to be the obvious choice. We aim...

Continue reading

Form 8.3 – [MARLOWE PLC – 21 07 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree MARLOWE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D

BEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), today announced the successful completion of its previously disclosed acquisition of Life Molecular Imaging Ltd. (“Life Molecular”), a subsidiary of Life Healthcare Group Holdings Ltd (“Life Healthcare”). As part of the acquisition, Ludger Dinkelborg, PhD, formerly CEO and Managing Director of Life Molecular Imaging, has been appointed Head of Research and Development at Lantheus effective August 1, 2025. “We are thrilled to welcome Dr. Dinkelborg and the entire Life Molecular team to Lantheus,” said Brian Markison, CEO of Lantheus. “Ludger’s proven leadership, scientific expertise, and track record of advancing innovative radiopharmaceuticals will be instrumental...

Continue reading

Old National Bancorp Reports Second Quarter 2025 Results and Names New President and COO

Timothy M. Burke, Jr.President and Chief Operating OfficerEVANSVILLE, Ind., July 22, 2025 (GLOBE NEWSWIRE) —Old National Bancorp (NASDAQ: ONB) reports 2Q25 net income applicable to common shares of $121.4 million, diluted EPS of $0.34; $190.9 million and $0.53 on an adjusted1 basis, respectively.CEO COMMENTARY:“Old National’s impressive second quarter results were achieved through a strong focus on the fundamentals: Growing our balance sheet, expanding our fee-based businesses, and controlling expenses,” said Chairman and CEO Jim Ryan. “Additionally, with the successful closing of our partnership with Bremer on May 1, 2025, Old National is well-positioned for the remainder of the year, benefiting from a larger balance sheet and a stronger capital position.” “We are thrilled to welcome...

Continue reading

Capital City Bank Group, Inc. Reports Second Quarter 2025 Results

TALLAHASSEE, Fla., July 22, 2025 (GLOBE NEWSWIRE) — Capital City Bank Group, Inc. (NASDAQ: CCBG) today reported net income attributable to common shareowners of $15.0 million, or $0.88 per diluted share, for the second quarter of 2025 compared to $16.9 million, or $0.99 per diluted share, for the first quarter of 2025, and $14.2 million, or $0.83 per diluted share, for the second quarter of 2024. QUARTER HIGHLIGHTS (2nd Quarter 2025 versus 1st Quarter 2025) Income StatementTax-equivalent net interest income totaled $43.2 million compared to $41.6 million for the first quarter of 2025Net interest margin increased eight basis points to 4.30% (earning asset yield increased by six basis points and cost of funds decreased two basis points to 82 basis points)Provision for credit losses decreased by $0.1 million to $0.6 million...

Continue reading

Interpublic Announces Second Quarter and First Half 2025 Results

New York, NY, July 22, 2025 (GLOBE NEWSWIRE) —Total revenue of $2.5 billion, including billable expensesRevenue before billable expenses (“net revenue”) of $2.2 billionOrganic net revenue decrease of -3.5% due to prior-year client account activityReported net income was $162.5 million, which includes after-tax expense of $88.4 million for previously announced strategic restructuring actionsAdjusted EBITA before restructuring charges and deal costs was $393.7 million with margin of 18.1% on revenue before billable expensesDiluted loss per share of $0.44 as reported and diluted earnings per share of $0.75 as adjustedPhilippe Krakowsky, CEO of Interpublic: “Organic revenue was in line with expectations, reflecting the impact of account activity in 2024. Underlying growth in the quarter showed sequential...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.